Scholtz & Company’s Express Scripts Holding Company ESRX Stock Holding History

Scholtz & Company’s Portfolio ESRX Stock Details ESRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-8,250	Closed	-$668K	–	51
2015 Q3	$668K	Sell	8,250 -800	-9%	-$69.7K	0.71%	39
2015 Q2	$805K	Sell	9,050 -3,550	-28%	-$310K	0.79%	39
2015 Q1	$1.09M	Sell	12,600 -500	-4%	-$41.9K	1.06%	33
2014 Q4	$1.11M	Sell	13,100 -4,825	-27%	-$377K	1.13%	30
2014 Q3	$1.27M	Sell	17,925 -4,650	-21%	-$331K	1.25%	31
2014 Q2	$1.56M	Sell	22,575 -1,225	-5%	-$86.2K	1.48%	31
2014 Q1	$1.79M	Buy	+23,800	New	+$1.78M	1.91%	22

Other funds holding ESRX

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Scholtz & Company's ESRX Position: Q4 2015 in Review

Scholtz & Company sold out of Express Scripts Holding Company (ESRX) in Q4 2015, closing a stake of 8,250 shares — an estimated $668K sold.

Scholtz & Company first reported a position in ESRX in Q1 2014 and held it in 7 quarters. The position peaked at $1.79M in Q1 2014. 1,295 funds tracked by Wall St. Rank hold ESRX as of Q4 2015.

Scholtz & Company reported no remaining Express Scripts Holding Company position as of Q4 2015 after selling out during the quarter.
Scholtz & Company sold 8,250 Express Scripts Holding Company shares in Q4 2015, an estimated $668K.
Scholtz & Company first reported a position in Express Scripts Holding Company in Q1 2014 and held it in 7 quarters.
Scholtz & Company's Express Scripts Holding Company position peaked at $1.79M in Q1 2014.
1,295 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2015.

Based on Scholtz & Company's 13F filing for Q4 2015, filed 12 Feb 2016.